Cargando…
Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial
AIM: To examine the metabolic, gluco-regulatory-hormonal and inflammatory cytokine responses to large reductions in rapid-acting insulin dose administered prandially before and after intensive running exercise in male type 1 diabetes patients. METHODS: This was a single centre, randomised, controlle...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032262/ https://www.ncbi.nlm.nih.gov/pubmed/24858952 http://dx.doi.org/10.1371/journal.pone.0097143 |
_version_ | 1782317618380668928 |
---|---|
author | Campbell, Matthew D. Walker, Mark Trenell, Michael I. Luzio, Steven Dunseath, Gareth Tuner, Daniel Bracken, Richard M. Bain, Stephen C. Russell, Mark Stevenson, Emma J. West, Daniel J. |
author_facet | Campbell, Matthew D. Walker, Mark Trenell, Michael I. Luzio, Steven Dunseath, Gareth Tuner, Daniel Bracken, Richard M. Bain, Stephen C. Russell, Mark Stevenson, Emma J. West, Daniel J. |
author_sort | Campbell, Matthew D. |
collection | PubMed |
description | AIM: To examine the metabolic, gluco-regulatory-hormonal and inflammatory cytokine responses to large reductions in rapid-acting insulin dose administered prandially before and after intensive running exercise in male type 1 diabetes patients. METHODS: This was a single centre, randomised, controlled open label study. Following preliminary testing, 8 male patients (24±2 years, HbA1c 7.7±0.4%/61±4 mmol.l(−1)) treated with insulin's glargine and aspart, or lispro attended the laboratory on two mornings at ∼08:00 h and consumed a standardised breakfast carbohydrate bolus (1 g carbohydrate.kg(−1)BM; 380±10 kcal) and self-administered a 75% reduced rapid-acting insulin dose 60 minutes before 45 minutes of intensive treadmill running at 73.1±0.9% VO(2peak). At 60 minutes post-exercise, patients ingested a meal (1 g carbohydrate.kg(−1)BM; 660±21 kcal) and administered either a Full or 50% reduced rapid-acting insulin dose. Blood glucose and lactate, serum insulin, cortisol, non-esterified-fatty-acids, β-Hydroxybutyrate, and plasma glucagon, adrenaline, noradrenaline, IL-6, and TNF-α concentrations were measured for 180 minutes post-meal. RESULTS: All participants were analysed. All glycaemic, metabolic, hormonal, and cytokine responses were similar between conditions up to 60 minutes following exercise. Following the post-exercise meal, serum insulin concentrations were lower under 50% (p<0.05) resulting in 75% of patients experiencing hyperglycaemia (blood glucose ≥8.0 mmol.l(−1); 50% n = 6, Full n = 3). β-Hydroxybutyrate concentrations decreased similarly, such that at 180 minutes post-meal concentrations were lower than rest under Full and 50%. IL-6 and TNF-α concentrations remained similar to fasting levels under 50% but declined under Full. Under 50% IL-6 concentrations were inversely related with serum insulin concentrations (r = −0.484, p = 0.017). CONCLUSIONS: Heavily reducing rapid-acting insulin dose with a carbohydrate bolus before, and a meal after intensive running exercise may cause hyperglycaemia, but does not augment ketonaemia, raise inflammatory cytokines TNF-α and IL-6 above fasting levels, or cause other adverse metabolic or hormonal disturbances. TRIAL REGISTRATION: ClinicalTrials.gov NCT01531855 |
format | Online Article Text |
id | pubmed-4032262 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40322622014-05-28 Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial Campbell, Matthew D. Walker, Mark Trenell, Michael I. Luzio, Steven Dunseath, Gareth Tuner, Daniel Bracken, Richard M. Bain, Stephen C. Russell, Mark Stevenson, Emma J. West, Daniel J. PLoS One Research Article AIM: To examine the metabolic, gluco-regulatory-hormonal and inflammatory cytokine responses to large reductions in rapid-acting insulin dose administered prandially before and after intensive running exercise in male type 1 diabetes patients. METHODS: This was a single centre, randomised, controlled open label study. Following preliminary testing, 8 male patients (24±2 years, HbA1c 7.7±0.4%/61±4 mmol.l(−1)) treated with insulin's glargine and aspart, or lispro attended the laboratory on two mornings at ∼08:00 h and consumed a standardised breakfast carbohydrate bolus (1 g carbohydrate.kg(−1)BM; 380±10 kcal) and self-administered a 75% reduced rapid-acting insulin dose 60 minutes before 45 minutes of intensive treadmill running at 73.1±0.9% VO(2peak). At 60 minutes post-exercise, patients ingested a meal (1 g carbohydrate.kg(−1)BM; 660±21 kcal) and administered either a Full or 50% reduced rapid-acting insulin dose. Blood glucose and lactate, serum insulin, cortisol, non-esterified-fatty-acids, β-Hydroxybutyrate, and plasma glucagon, adrenaline, noradrenaline, IL-6, and TNF-α concentrations were measured for 180 minutes post-meal. RESULTS: All participants were analysed. All glycaemic, metabolic, hormonal, and cytokine responses were similar between conditions up to 60 minutes following exercise. Following the post-exercise meal, serum insulin concentrations were lower under 50% (p<0.05) resulting in 75% of patients experiencing hyperglycaemia (blood glucose ≥8.0 mmol.l(−1); 50% n = 6, Full n = 3). β-Hydroxybutyrate concentrations decreased similarly, such that at 180 minutes post-meal concentrations were lower than rest under Full and 50%. IL-6 and TNF-α concentrations remained similar to fasting levels under 50% but declined under Full. Under 50% IL-6 concentrations were inversely related with serum insulin concentrations (r = −0.484, p = 0.017). CONCLUSIONS: Heavily reducing rapid-acting insulin dose with a carbohydrate bolus before, and a meal after intensive running exercise may cause hyperglycaemia, but does not augment ketonaemia, raise inflammatory cytokines TNF-α and IL-6 above fasting levels, or cause other adverse metabolic or hormonal disturbances. TRIAL REGISTRATION: ClinicalTrials.gov NCT01531855 Public Library of Science 2014-05-23 /pmc/articles/PMC4032262/ /pubmed/24858952 http://dx.doi.org/10.1371/journal.pone.0097143 Text en © 2014 Campbell et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Campbell, Matthew D. Walker, Mark Trenell, Michael I. Luzio, Steven Dunseath, Gareth Tuner, Daniel Bracken, Richard M. Bain, Stephen C. Russell, Mark Stevenson, Emma J. West, Daniel J. Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial |
title | Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial |
title_full | Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial |
title_fullStr | Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial |
title_full_unstemmed | Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial |
title_short | Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial |
title_sort | metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032262/ https://www.ncbi.nlm.nih.gov/pubmed/24858952 http://dx.doi.org/10.1371/journal.pone.0097143 |
work_keys_str_mv | AT campbellmatthewd metabolicimplicationswhenemployingheavypreandpostexerciserapidactinginsulinreductionstopreventhypoglycaemiaintype1diabetespatientsarandomisedclinicaltrial AT walkermark metabolicimplicationswhenemployingheavypreandpostexerciserapidactinginsulinreductionstopreventhypoglycaemiaintype1diabetespatientsarandomisedclinicaltrial AT trenellmichaeli metabolicimplicationswhenemployingheavypreandpostexerciserapidactinginsulinreductionstopreventhypoglycaemiaintype1diabetespatientsarandomisedclinicaltrial AT luziosteven metabolicimplicationswhenemployingheavypreandpostexerciserapidactinginsulinreductionstopreventhypoglycaemiaintype1diabetespatientsarandomisedclinicaltrial AT dunseathgareth metabolicimplicationswhenemployingheavypreandpostexerciserapidactinginsulinreductionstopreventhypoglycaemiaintype1diabetespatientsarandomisedclinicaltrial AT tunerdaniel metabolicimplicationswhenemployingheavypreandpostexerciserapidactinginsulinreductionstopreventhypoglycaemiaintype1diabetespatientsarandomisedclinicaltrial AT brackenrichardm metabolicimplicationswhenemployingheavypreandpostexerciserapidactinginsulinreductionstopreventhypoglycaemiaintype1diabetespatientsarandomisedclinicaltrial AT bainstephenc metabolicimplicationswhenemployingheavypreandpostexerciserapidactinginsulinreductionstopreventhypoglycaemiaintype1diabetespatientsarandomisedclinicaltrial AT russellmark metabolicimplicationswhenemployingheavypreandpostexerciserapidactinginsulinreductionstopreventhypoglycaemiaintype1diabetespatientsarandomisedclinicaltrial AT stevensonemmaj metabolicimplicationswhenemployingheavypreandpostexerciserapidactinginsulinreductionstopreventhypoglycaemiaintype1diabetespatientsarandomisedclinicaltrial AT westdanielj metabolicimplicationswhenemployingheavypreandpostexerciserapidactinginsulinreductionstopreventhypoglycaemiaintype1diabetespatientsarandomisedclinicaltrial |